JP2023520188A5 - - Google Patents
Info
- Publication number
- JP2023520188A5 JP2023520188A5 JP2022557130A JP2022557130A JP2023520188A5 JP 2023520188 A5 JP2023520188 A5 JP 2023520188A5 JP 2022557130 A JP2022557130 A JP 2022557130A JP 2022557130 A JP2022557130 A JP 2022557130A JP 2023520188 A5 JP2023520188 A5 JP 2023520188A5
- Authority
- JP
- Japan
- Prior art keywords
- xaa
- independently
- amino acid
- pharmaceutically acceptable
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062994779P | 2020-03-25 | 2020-03-25 | |
| US62/994,779 | 2020-03-25 | ||
| US202063001455P | 2020-03-29 | 2020-03-29 | |
| US63/001,455 | 2020-03-29 | ||
| US202063055860P | 2020-07-23 | 2020-07-23 | |
| US63/055,860 | 2020-07-23 | ||
| PCT/US2021/024186 WO2021195401A1 (en) | 2020-03-25 | 2021-03-25 | Technologies for preventing or treating infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023520188A JP2023520188A (ja) | 2023-05-16 |
| JP2023520188A5 true JP2023520188A5 (https=) | 2024-04-03 |
Family
ID=77890439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022557130A Pending JP2023520188A (ja) | 2020-03-25 | 2021-03-25 | 感染を予防又は治療するための技術 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230330240A1 (https=) |
| EP (1) | EP4125893A4 (https=) |
| JP (1) | JP2023520188A (https=) |
| KR (1) | KR20220158762A (https=) |
| CN (1) | CN115697415A (https=) |
| AU (1) | AU2021244228A1 (https=) |
| BR (1) | BR112022018945A2 (https=) |
| CA (1) | CA3176256A1 (https=) |
| IL (1) | IL296725A (https=) |
| MX (1) | MX2022011692A (https=) |
| PH (1) | PH12022552499A1 (https=) |
| WO (1) | WO2021195401A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022159372A1 (en) | 2021-01-22 | 2022-07-28 | Decoy Therapeutics, Inc. | Methods and compositions for treating infections |
| WO2023150375A2 (en) * | 2022-02-07 | 2023-08-10 | Decoy Therapeutics Inc. | Methods and compositions for treating covid infections |
| CN116440285A (zh) * | 2023-04-19 | 2023-07-18 | 山西锦波生物医药股份有限公司 | 冠状病毒多肽类融合抑制剂的长效化的方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3069986A1 (en) * | 2017-07-26 | 2019-01-31 | Kleo Pharmaceuticals, Inc. | Universal abt compounds and uses thereof |
-
2021
- 2021-03-25 AU AU2021244228A patent/AU2021244228A1/en not_active Abandoned
- 2021-03-25 US US17/912,563 patent/US20230330240A1/en active Pending
- 2021-03-25 KR KR1020227036445A patent/KR20220158762A/ko active Pending
- 2021-03-25 MX MX2022011692A patent/MX2022011692A/es unknown
- 2021-03-25 IL IL296725A patent/IL296725A/en unknown
- 2021-03-25 EP EP21775066.0A patent/EP4125893A4/en active Pending
- 2021-03-25 WO PCT/US2021/024186 patent/WO2021195401A1/en not_active Ceased
- 2021-03-25 CN CN202180035832.5A patent/CN115697415A/zh active Pending
- 2021-03-25 JP JP2022557130A patent/JP2023520188A/ja active Pending
- 2021-03-25 BR BR112022018945A patent/BR112022018945A2/pt unknown
- 2021-03-25 CA CA3176256A patent/CA3176256A1/en active Pending
- 2021-03-25 PH PH1/2022/552499A patent/PH12022552499A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023520188A5 (https=) | ||
| ES2664872T3 (es) | Moduladores PRPK-TPRKB y sus usos | |
| US11208390B2 (en) | Functionalized 1,2,4,5-tetrazine compounds for use in bioorthogonal coupling reactions | |
| JP2021528470A5 (https=) | ||
| US11192866B2 (en) | Synthesis of tetracyclines and analogues thereof | |
| AU2006259415B2 (en) | Amine-containing lipids and uses thereof | |
| US9458189B2 (en) | Ligation of stapled polypeptides | |
| US20150284437A1 (en) | Beta-catenin targeting peptides and uses thereof | |
| US10155742B2 (en) | Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions | |
| JP2015221832A5 (https=) | ||
| KR20230057350A (ko) | 스테이플화된 펩티드 및 이의 방법 | |
| US20090093640A1 (en) | Synthesis of enone intermediate | |
| US20240309049A1 (en) | Synthetic dna binding domain peptides and uses thereof | |
| US20230330240A1 (en) | Technologies for preventing or treating infections | |
| US20200282048A1 (en) | Use of imidazopyrimidine for modulating human immune response | |
| WO2022178425A1 (en) | Targeted bifunctional degraders | |
| US20240335555A1 (en) | Technologies for preventing or treating infections | |
| AU2022328282A1 (en) | Treatment of jak-inhibition-responsive disorders with prodrugs of jak inhibitors | |
| WO2010009403A2 (en) | Methods for treating arthritis and other inflammatory or autoimmune diseases | |
| US11530250B2 (en) | Tyrosine-specific functionalized insulin and insulin analogs | |
| US20240391956A1 (en) | Stapled peptides and methods thereof | |
| WO2017158168A1 (en) | Inhibitors of talin-vinculin binding for the treatment of cancer | |
| BR122025002050A2 (pt) | Composto degradador bifuncional direcionado, composição farmacêutica compreendendo o mesmo e uso terapêutico dos mesmos | |
| KR20260035134A (ko) | 스테이플화 펩티드 및 이의 방법 | |
| AU2012202559B2 (en) | Synthesis of tetracyclines and analogues thereof |